SCHEMBL9703876

SCHEMBL9703876

c1ccc(C(NCCCN2CCCCC2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 4/20 0.56
CHRM1 P11229 4/20 0.56
CYP2D6 P10635 4/20 0.56
SIGMAR1 Q99720 4/20 0.56
CHRM3 P20309 3/20 0.56
KCNH2 Q12809 3/20 0.56
CHRM4 P08173 2/20 0.56
CHRM5 P08912 2/20 0.56
HTR1A P08908 2/20 0.56
OPRM1 P35372 2/20 0.56
KDM4E B2RXH2 1/20 0.56
DRD2 P14416 1/20 0.56
DRD1 P21728 1/20 0.56
HTR2A P28223 1/20 0.56
DRD3 P35462 1/20 0.56
SCN1A P35498 1/20 0.56
SCN2A Q99250 1/20 0.56
SCN3A Q9NY46 1/20 0.56
LMNA P02545 2/20 0.55
MAPK1 P28482 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9704880 0.90 CYP2D6 (0.54) CHRM2CHRM1CYP2D6SIGMAR1CHRM3
SCHEMBL12264133 0.76 KIF11 (0.68) SIGMAR1DUTKIF11
SCHEMBL9740035 0.75 KCNH2 (0.64) SIGMAR1KCNH2HTR1ADRD2HTR2A
SCHEMBL11090932 0.75 HRH3 (0.61) SIGMAR1HRH3KMT2AHRH1
SCHEMBL5755487 0.75 HRH3 (0.61) SIGMAR1HRH3KMT2AHRH1
SCHEMBL14744149 0.74 CHRM2 (0.54) CHRM2CHRM1CYP2D6SIGMAR1CHRM3
SCHEMBL28307561 0.74 CHRM2 (0.51) CHRM2CHRM1CYP2D6SIGMAR1CHRM3
Hydrochloric Acid SCHEMBL5754818 0.73 HRH3 (0.60) CHRM2CHRM1SIGMAR1CHRM3CHRM4
SCHEMBL11093254 0.73 HRH3 (0.59) SIGMAR1HRH3KMT2ADPP7HRH1
Diphenidol SCHEMBL34469 0.72 CHRM3 (1.00) CHRM2CHRM1CYP2D6SIGMAR1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0480794-A1 2-Aminopyrimidine-4-carboxamide derivatives, their preparation and therapeutic use SYNTHELABO (FR) 1992-04-15 EP disclosed